Hypertension exercise significantly reduced blood pressure in elderly patients, eliminating stage 2 hypertension and shifting 45.1% of participants to high normal blood pressure (p=0.000).
Does hypertension exercise reduce blood pressure in elderly patients with hypertension?
Hypertension exercise is an effective non-pharmacological intervention to significantly reduce blood pressure in elderly patients.
p-value: p=0.000
Hypertension is when systolic blood pressure is greater than 140 mmHg, and diastolic blood pressure is greater than 90 mmHg caused by complex factors and related conditions. Hypertension in the elderly often occurs because cell structure and function change with increasing age, affecting health and disease. Sports such as hypertension exercise can encourage the heart to work optimally. The blood vessels will stretch, and blood flow will decrease temporarily for about 30-120 minutes. It will return to blood pressure before doing the exercise. This study aims to determine the effect of hypertension exercise on blood pressure in the elderly in Legonkulon village, Subang regency, West Java, Indonesia, in 2022. This quantitative research method has a Pre-experiment design one group. The population in this study were all hypertensive elderly in Legonkulon Village, 104 people in the UPTD Puskesmas Legonkulon Subang Regency. Sampling using the formula Slovin with purposive sampling technique as many as 51 people meet the research criteria. The instruments used are an aneroid spectrum sphygmomanometer, stethoscope, and observation sheet. The data analysis technique used is the Wilcoxon Signed Rank Test. The results of statistical tests obtained p-value = 0.000. The hypothesis concludes that hypertension exercise affects blood pressure in the elderly.
Abdurakhman et al. (Wed,) conducted a other in Hypertension (n=51). Hypertension exercise vs. Baseline (pre-test) was evaluated on Change in blood pressure category (p=0.000). Hypertension exercise significantly reduced blood pressure in elderly patients, eliminating stage 2 hypertension and shifting 45.1% of participants to high normal blood pressure (p=0.000).